City State Bank’s Inovio Pharmaceuticals INO Stock Holding History

City State Bank’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-183	Closed	-$1.06K	–	741
2024 Q3	$1.06K	Hold	183	–	–	﹤0.01%	678
2024 Q2	$1.48K	Hold	183	–	–	﹤0.01%	645
2024 Q1	$3K	Hold	183	–	–	﹤0.01%	619
2023 Q4	$1K	Hold	183	–	–	﹤0.01%	654
2023 Q3	$1K	Hold	183	–	–	﹤0.01%	664
2023 Q2	$1K	Hold	183	–	–	﹤0.01%	673
2023 Q1	$2K	Buy	+183	New	+$3.12K	﹤0.01%	629
2022 Q4	–	Sell	-167	Closed	-$3K	–	678
2022 Q3	$3K	Hold	167	–	–	﹤0.01%	576
2022 Q2	$3K	Hold	167	–	–	﹤0.01%	577
2022 Q1	$7K	Hold	167	–	–	﹤0.01%	513
2021 Q4	$10K	Buy	+167	New	+$13.4K	0.01%	467

Other funds holding INO

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

City State Bank's INO Position: Q4 2024 in Review

City State Bank sold out of Inovio Pharmaceuticals (INO) in Q4 2024, closing a stake of 183 shares — an estimated $1.06K sold.

City State Bank first reported a position in INO in Q4 2021 and held it in 11 quarters. The position peaked at $10K in Q4 2021. 104 funds tracked by Wall St. Rank hold INO as of Q4 2024.

City State Bank reported no remaining Inovio Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
City State Bank sold 183 Inovio Pharmaceuticals shares in Q4 2024, an estimated $1.06K.
City State Bank first reported a position in Inovio Pharmaceuticals in Q4 2021 and held it in 11 quarters.
City State Bank's Inovio Pharmaceuticals position peaked at $10K in Q4 2021.
104 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q4 2024.

Based on City State Bank's 13F filing for Q4 2024, filed 13 Jan 2025.